Literature DB >> 24445797

[Marfan syndrome and valvular disease].

M Pasic1, M Bauer, R Hetzer.   

Abstract

Marfan syndrome is a hereditary disease of the connective tissue with increased mortality mostly due to changes of the cardiovascular system. We describe our experience with the surgical treatment of 243 patients with Marfan syndrome and cardiovascular complications. We report the results of treatment of annulo-aortal ectasia using the classical surgical methods of Bentall DeBono and Cabrol and the method for preservation of the native aortic valve and concomitant surgery of the mitral valve. Reconstruction or replacement of the mitral valve is mainly based on the classical indications. Preservation of the native aortic valve and reconstruction of the mitral valve in patients with Marfan syndrome is possible but the long-term results are still unknown.

Entities:  

Year:  2001        PMID: 24445797     DOI: 10.1007/s003920170017

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  22 in total

1.  Composite valve graft replacement of the proximal aorta: comparison of techniques in 348 patients.

Authors:  L G Svensson; E S Crawford; K R Hess; J S Coselli; H J Safi
Journal:  Ann Thorac Surg       Date:  1992-09       Impact factor: 4.330

2.  Marfan syndrome.

Authors:  R E Pyeritz
Journal:  N Engl J Med       Date:  1990-10-04       Impact factor: 91.245

3.  Revised diagnostic criteria for the Marfan syndrome.

Authors:  A De Paepe; R B Devereux; H C Dietz; R C Hennekam; R E Pyeritz
Journal:  Am J Med Genet       Date:  1996-04-24

Review 4.  The Marfan syndrome: diagnosis and management.

Authors:  R E Pyeritz; V A McKusick
Journal:  N Engl J Med       Date:  1979-04-05       Impact factor: 91.245

5.  Surgery of proximal aorta in Marfan's syndrome.

Authors:  I K Crosby; W C Ashcraft; W A Reed
Journal:  J Thorac Cardiovasc Surg       Date:  1973-07       Impact factor: 5.209

6.  Location on chromosome 15 of the gene defect causing Marfan syndrome.

Authors:  K Kainulainen; L Pulkkinen; A Savolainen; I Kaitila; L Peltonen
Journal:  N Engl J Med       Date:  1990-10-04       Impact factor: 91.245

7.  When, why, and how should the native aortic valve be preserved in patients with annuloaortic ectasia or Marfan syndrome?

Authors:  T E David
Journal:  Semin Thorac Cardiovasc Surg       Date:  1993-01

8.  Remodeling of the aortic valve anulus.

Authors:  M A Sarsam; M Yacoub
Journal:  J Thorac Cardiovasc Surg       Date:  1993-03       Impact factor: 5.209

9.  Marfan's syndrome. Broad spectral surgical treatment cardiovascular manifestations.

Authors:  E S Crawford
Journal:  Ann Surg       Date:  1983-10       Impact factor: 12.969

10.  Impact of cardiovascular operation on survival in the Marfan patient.

Authors:  L G Svensson; E S Crawford; J S Coselli; H J Safi; K R Hess
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

View more
  1 in total

Review 1.  [Antithrombotic therapy in atrial fibrillation: when vitamin K antagonists? When aspirin? When heparin? When combinations of anticoagulant and antiplatelet drugs?].

Authors:  H Volkmann; M Walter; C Bergmann; E Rose; V Krpciar; S Vetter
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.